Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C26H38O4 |
| Molecular Weight | 414.5775 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@]12CC[C@H]3[C@@H](CCC4=C(O)C(=O)CC[C@H]34)[C@@H]1CC[C@@H]2OC(=O)CCC5CCCC5
InChI
InChIKey=KHKDIUPVDIEHAH-KXLSUQFWSA-N
InChI=1S/C26H38O4/c1-26-15-14-18-17-9-11-22(27)25(29)20(17)8-7-19(18)21(26)10-12-23(26)30-24(28)13-6-16-4-2-3-5-16/h16-19,21,23,29H,2-15H2,1H3/t17-,18-,19-,21+,23+,26+/m1/s1
DescriptionCurator's Comment: Description was created based on several sources, including http://pilarmartinescudero.es/EneroFebreroMarzo2014/capillary_investigation_oxabolone_man.pdf and http://www.basskilleronline.com/profile-steranabol.shtml
Curator's Comment: Description was created based on several sources, including http://pilarmartinescudero.es/EneroFebreroMarzo2014/capillary_investigation_oxabolone_man.pdf and http://www.basskilleronline.com/profile-steranabol.shtml
Oxabolone is a synthetic anabolic steroid. It can be formulated as the cipionate ester prodrug oxabolone cipionate. Oxabolone cypionate is a structural derivative of nandrolone. It differs via the additional 4-hydroxyl group that is attached, therefore making oxabolone cypionate 4-hydroxynandrolone. Oxabolone is on the World Anti-Doping Agency's list of prohibited substances, and is therefore banned from use in most major sports. Oxabolone cypionate is a relatively rare drug that was once produced in Europe for human use. Was used for the treatment of osteoporosis. It is no longer produced by pharmaceutical companies; Upjohn and Pharmacia were the primary producers of it previously.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL1871 Sources: http://www.kegg.jp/entry/D01149 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Palliative | Unknown Approved UseUnknown |
|||
Sources: http://www.ndrugs.com/?s=steranabol |
Primary | Steranabol Approved UseIndications: anabolic, osteoporosis, diabetic retinopathy |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QA14AB03
Created by
admin on Mon Mar 31 18:17:28 GMT 2025 , Edited by admin on Mon Mar 31 18:17:28 GMT 2025
|
||
|
WHO-ATC |
A14AB03
Created by
admin on Mon Mar 31 18:17:28 GMT 2025 , Edited by admin on Mon Mar 31 18:17:28 GMT 2025
|
||
|
NCI_THESAURUS |
C2360
Created by
admin on Mon Mar 31 18:17:28 GMT 2025 , Edited by admin on Mon Mar 31 18:17:28 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL2105318
Created by
admin on Mon Mar 31 18:17:28 GMT 2025 , Edited by admin on Mon Mar 31 18:17:28 GMT 2025
|
PRIMARY | |||
|
m379
Created by
admin on Mon Mar 31 18:17:28 GMT 2025 , Edited by admin on Mon Mar 31 18:17:28 GMT 2025
|
PRIMARY | Merck Index | ||
|
522767
Created by
admin on Mon Mar 31 18:17:28 GMT 2025 , Edited by admin on Mon Mar 31 18:17:28 GMT 2025
|
PRIMARY | |||
|
DB13185
Created by
admin on Mon Mar 31 18:17:28 GMT 2025 , Edited by admin on Mon Mar 31 18:17:28 GMT 2025
|
PRIMARY | |||
|
C81376
Created by
admin on Mon Mar 31 18:17:28 GMT 2025 , Edited by admin on Mon Mar 31 18:17:28 GMT 2025
|
PRIMARY | |||
|
68952
Created by
admin on Mon Mar 31 18:17:28 GMT 2025 , Edited by admin on Mon Mar 31 18:17:28 GMT 2025
|
PRIMARY | |||
|
1254-35-9
Created by
admin on Mon Mar 31 18:17:28 GMT 2025 , Edited by admin on Mon Mar 31 18:17:28 GMT 2025
|
PRIMARY | |||
|
4681
Created by
admin on Mon Mar 31 18:17:28 GMT 2025 , Edited by admin on Mon Mar 31 18:17:28 GMT 2025
|
PRIMARY | |||
|
SUB09481MIG
Created by
admin on Mon Mar 31 18:17:28 GMT 2025 , Edited by admin on Mon Mar 31 18:17:28 GMT 2025
|
PRIMARY | |||
|
5RXY50Q01N
Created by
admin on Mon Mar 31 18:17:28 GMT 2025 , Edited by admin on Mon Mar 31 18:17:28 GMT 2025
|
PRIMARY | |||
|
100000083576
Created by
admin on Mon Mar 31 18:17:28 GMT 2025 , Edited by admin on Mon Mar 31 18:17:28 GMT 2025
|
PRIMARY | |||
|
215-011-8
Created by
admin on Mon Mar 31 18:17:28 GMT 2025 , Edited by admin on Mon Mar 31 18:17:28 GMT 2025
|
PRIMARY | |||
|
DTXSID3046879
Created by
admin on Mon Mar 31 18:17:28 GMT 2025 , Edited by admin on Mon Mar 31 18:17:28 GMT 2025
|
PRIMARY | |||
|
OXABOLONE CIPIONATE
Created by
admin on Mon Mar 31 18:17:28 GMT 2025 , Edited by admin on Mon Mar 31 18:17:28 GMT 2025
|
PRIMARY | |||
|
1684
Created by
admin on Mon Mar 31 18:17:28 GMT 2025 , Edited by admin on Mon Mar 31 18:17:28 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD